Annovis BioInc Current Financial Leverage

ANVS Stock  USD 11.78  0.12  1.01%   
Annovis BioInc holds a debt-to-equity ratio of -0.313. Net Debt is likely to gain to about (24.3 M) in 2024. Short and Long Term Debt Total is likely to drop to about 399.8 K in 2024Annovis BioInc's financial risk is the risk to Annovis BioInc stockholders that is caused by an increase in debt. In other words, with a high degree of financial leverage come high-interest payments, which usually reduce Earnings Per Share (EPS).
Net Debt is likely to gain to about (24.3 M) in 2024. Short and Long Term Debt Total is likely to drop to about 399.8 K in 2024
  
Check out the analysis of Annovis BioInc Fundamentals Over Time.
For more information on how to buy Annovis Stock please use our How to Invest in Annovis BioInc guide.

Annovis BioInc Financial Leverage Rating

Annovis BioInc bond ratings play a critical role in determining how much Annovis BioInc have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for Annovis BioInc's borrowing costs.
Piotroski F Score
3  Frail
Beneish M Score

Annovis BioInc Debt to Cash Allocation

As Annovis BioInc follows its natural business cycle, the capital allocation decisions will not magically go away. Annovis BioInc's decision-makers have to determine if most of the cash flows will be poured back into or reinvested in the business, reserved for other projects beyond operational needs, or paid back to stakeholders and investors. Many companies eventually find out that there is only so much market out there to be conquered, and adding the next product or service is only half as profitable per unit as their current endeavors. Eventually, the company will reach a point where cash flows are strong, and extra cash is available but not fully utilized. In this case, the company may start buying back its stock from the public or issue more dividends.
The company has a current ratio of 27.55, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Annovis BioInc until it has trouble settling it off, either with new capital or with free cash flow. So, Annovis BioInc's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Annovis BioInc sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Annovis to invest in growth at high rates of return. When we think about Annovis BioInc's use of debt, we should always consider it together with cash and equity.

Annovis BioInc Total Assets Over Time

Annovis BioInc Assets Financed by Debt

Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Annovis BioInc's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Annovis BioInc, which in turn will lower the firm's financial flexibility. Like all other financial ratios, a an Annovis BioInc debt ratio should be compared their industry average or other competing firms.

Annovis Net Debt

Net Debt

(24.26 Million)

At this time, Annovis BioInc's Net Debt is comparatively stable compared to the past year.

Understaning Annovis BioInc Use of Financial Leverage

Annovis BioInc financial leverage ratio helps in determining the effect of debt on the overall profitability of the company. It measures Annovis BioInc's total debt position, including all of outstanding debt obligations, and compares it with the equity. In simple terms, the high financial leverage means the cost of production, together with running the business day-to-day, is high, whereas, lower financial leverage implies lower fixed cost investment in the business and generally considered by investors to be a good sign. So if creditors own a majority of Annovis BioInc assets, the company is considered highly leveraged. Understanding the composition and structure of overall Annovis BioInc debt and outstanding corporate bonds gives a good idea of how risky the capital structure of a business and if it is worth investing in it. Financial leverage can amplify the potential profits to Annovis BioInc's owners, but it also increases the potential losses and risk of financial distress, including bankruptcy, if the firm cannot cover its debt costs. The degree of Annovis BioInc's financial leverage can be measured in several ways, including by ratios such as the debt-to-equity ratio (total debt / total equity), equity multiplier (total assets / total equity), or the debt ratio (total debt / total assets).
Last ReportedProjected for 2024
Net Debt-25.5 M-24.3 M
Short and Long Term Debt Total449.8 K399.8 K
Long Term Debt449.8 K399.8 K
Long Term Debt Total449.8 K399.8 K
Long Term Debt To Capitalization(0.06)(0.06)
Total Debt To Capitalization(0.06)(0.06)
Debt Equity Ratio(0.05)(0.06)
Debt Ratio 0.40  0.36 
Cash Flow To Debt Ratio(0.86)(0.90)
Please read more on our technical analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Annovis BioInc in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Annovis BioInc's short interest history, or implied volatility extrapolated from Annovis BioInc options trading.

Pair Trading with Annovis BioInc

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Annovis BioInc position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Annovis BioInc will appreciate offsetting losses from the drop in the long position's value.

Moving together with Annovis Stock

  0.63MBRX Moleculin Biotech Upward RallyPairCorr
  0.62MCRB Seres Therapeutics Financial Report 14th of May 2024 PairCorr

Moving against Annovis Stock

  0.71MGNX MacroGenics Financial Report 14th of May 2024 PairCorr
  0.66DNTH Dianthus Therapeutics Symbol ChangePairCorr
  0.64MRK Merck Company Fiscal Quarter End 31st of March 2024 PairCorr
  0.6MDWD Mediwound Financial Report 4th of June 2024 PairCorr
  0.58EQ Equillium Financial Report 9th of May 2024 PairCorr
The ability to find closely correlated positions to Annovis BioInc could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Annovis BioInc when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Annovis BioInc - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Annovis BioInc to buy it.
The correlation of Annovis BioInc is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Annovis BioInc moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Annovis BioInc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Annovis BioInc can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Annovis BioInc is a strong investment it is important to analyze Annovis BioInc's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Annovis BioInc's future performance. For an informed investment choice regarding Annovis Stock, refer to the following important reports:
Check out the analysis of Annovis BioInc Fundamentals Over Time.
For more information on how to buy Annovis Stock please use our How to Invest in Annovis BioInc guide.
You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.

Complementary Tools for Annovis Stock analysis

When running Annovis BioInc's price analysis, check to measure Annovis BioInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Annovis BioInc is operating at the current time. Most of Annovis BioInc's value examination focuses on studying past and present price action to predict the probability of Annovis BioInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Annovis BioInc's price. Additionally, you may evaluate how the addition of Annovis BioInc to your portfolios can decrease your overall portfolio volatility.
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Equity Valuation
Check real value of public entities based on technical and fundamental data
Is Annovis BioInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Annovis BioInc. If investors know Annovis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Annovis BioInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(4.84)
Return On Assets
(1.24)
Return On Equity
(2.28)
The market value of Annovis BioInc is measured differently than its book value, which is the value of Annovis that is recorded on the company's balance sheet. Investors also form their own opinion of Annovis BioInc's value that differs from its market value or its book value, called intrinsic value, which is Annovis BioInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Annovis BioInc's market value can be influenced by many factors that don't directly affect Annovis BioInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Annovis BioInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Annovis BioInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Annovis BioInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

What is Financial Leverage?

Financial leverage is the use of borrowed money (debt) to finance the purchase of assets with the expectation that the income or capital gain from the new asset will exceed the cost of borrowing. In most cases, the debt provider will limit how much risk it is ready to take and indicate a limit on the extent of the leverage it will allow. In the case of asset-backed lending, the financial provider uses the assets as collateral until the borrower repays the loan. In the case of a cash flow loan, the general creditworthiness of the company is used to back the loan. The concept of leverage is common in the business world. It is mostly used to boost the returns on equity capital of a company, especially when the business is unable to increase its operating efficiency and returns on total investment. Because earnings on borrowing are higher than the interest payable on debt, the company's total earnings will increase, ultimately boosting stockholders' profits.

Leverage and Capital Costs

The debt to equity ratio plays a role in the working average cost of capital (WACC). The overall interest on debt represents the break-even point that must be obtained to profitability in a given venture. Thus, WACC is essentially the average interest an organization owes on the capital it has borrowed for leverage. Let's say equity represents 60% of borrowed capital, and debt is 40%. This results in a financial leverage calculation of 40/60, or 0.6667. The organization owes 10% on all equity and 5% on all debt. That means that the weighted average cost of capital is (.4)(5) + (.6)(10) - or 8%. For every $10,000 borrowed, this organization will owe $800 in interest. Profit must be higher than 8% on the project to offset the cost of interest and justify this leverage.

Benefits of Financial Leverage

Leverage provides the following benefits for companies:
  • Leverage is an essential tool a company's management can use to make the best financing and investment decisions.
  • It provides a variety of financing sources by which the firm can achieve its target earnings.
  • Leverage is also an essential technique in investing as it helps companies set a threshold for the expansion of business operations. For example, it can be used to recommend restrictions on business expansion once the projected return on additional investment is lower than the cost of debt.
By borrowing funds, the firm incurs a debt that must be paid. But, this debt is paid in small installments over a relatively long period of time. This frees funds for more immediate use in the stock market. For example, suppose a company can afford a new factory but will be left with negligible free cash. In that case, it may be better to finance the factory and spend the cash on hand on inputs, labor, or even hold a significant portion as a reserve against unforeseen circumstances.

The Risk of Financial Leverage

The most obvious and apparent risk of leverage is that if price changes unexpectedly, the leveraged position can lead to severe losses. For example, imagine a hedge fund seeded by $50 worth of investor money. The hedge fund borrows another $50 and buys an asset worth $100, leading to a leverage ratio of 2:1. For the investor, this is neither good nor bad -- until the asset price changes. If the asset price goes up 10 percent, the investor earns $10 on $50 of capital, a net gain of 20 percent, and is very pleased with the increased gains from the leverage. However, if the asset price crashes unexpectedly, say by 30 percent, the investor loses $30 on $50 of capital, suffering a 60 percent loss. In other words, the effect of leverage is to increase the volatility of returns and increase the effects of a price change on the asset to the bottom line while increasing the chance for profit as well.